Owens, MD, Christopher Tessier, MD Jennifer Bertsch, Margaret Hoogland (Medical Librarian), Heddy Hubbard, Ph D, MPH, RN, FAAN, Suzanne Pope, MBA, Stephanie Stinchcomb, CPC, CCS-P, ACS-UR, Cecelia Shertz Wall (Medical Writer), Marni Yoffe, MA (Methodologist), Kathleen Zwarick, Ph D, CAE Introduction: Medication-related problems are common but may be preventable outcomes of prescribing choices.
This study identified 48 individual medications or classes of medications to avoid in older adults and their potential concerns and 20 diseases/conditions and medications to be avoided in older adults with these conditions.
Of these potentially inappropriate drugs, 66 were considered by the panel to have adverse outcomes of high severity.
Several medications included in sections of the Beers Criteria are frequently used in clinical urology, including nitrofurantoin, the alpha1 blocker medications, and the antimuscarinic anticholinergic medications for the treatment of urge incontinence and overactive bladder.
In 2012, the American Geriatrics Society (AGS) published the most recent update of the Beers Criteria for Potentially Inappropriate Medication (PIM) Use in Older Adults.
STOPP identified 336 PIMs affecting 247 patients (35%), of whom one-third ( = 82) presented with an associated ADE.
Beers’ criteria identified 226 PIMs affecting 177 patients (25%), of whom 43 presented with an associated ADE.
Results: The rationale for creation and implementation of the Beers Criteria and its implications for urologic practice are reviewed.
Careful examination of the Beers Criteria can help clinicians to avoid potentially inappropriate prescribing choices for their geriatric patients.
The criteria are used in geriatrics clinical care to monitor and improve the quality of care.
They are also used in training, research, and healthcare policy to assist in developing performance measures and document outcomes.
This study is an important update of previously established criteria that have been widely used and cited.